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Summary
The presence of endocrine-disrupting compounds in wastewater, surface water, ground-
water and even drinking water has become a major concern worldwide, since they negati-
vely affect wildlife and humans. Therefore, these substances should be effectively removed
from effluents before they are discharged into surface water to prevent pollution of ground-
water, which can be a source of drinking water. Furthermore, an efficient control of endo-
crine-disrupting compounds in wastewater based on biological and analytical techniques
is required. In this study, a yeast estrogen screen (YES) bioassay has been introduced and
optimized with the aim to assess potential estrogenic activity of waters. First, assay dura-
tion, concentration of added substrate to the assay medium and wavelength used to mea-
sure the absorbance of the substrate were estimated. Several compounds, such as 17-b-estra-
diol, 17-a-ethinylestradiol, bisphenol A, nonylphenol, genisteine, hydrocortisone, dieldrin,
atrazine, methoxychlor, testosterone and progesterone were used to verify its specificity
and sensitivity. The optimized YES assay was sensitive and responded specifically to the
selected estrogenic and nonestrogenic compounds in aqueous samples. Potential estrogeni-
city of influent and effluent samples of two wastewater treatment plants was assessed af-
ter the samples had been concentrated by solid-phase extraction (SPE) procedure using
Oasis® HLB cartridges and methanol as eluting solvent. Up to 90 % of relative estrogenic
activity was detected in concentrated samples of influents to wastewater treatment plants
and estrogenic activity was still present in the concentrated effluent samples. We found
that the introduced YES assay is a suitable screening tool for monitoring the potential
estrogenicity of effluents that are discharged into surface water.
Key words: endocrine-disrupting compounds, estrogenic activity, monitoring, solid-phase
extraction, yeast estrogen screen assay, water
Introduction
Endocrine-disrupting compounds (EDCs) comprise a
wide range of natural and synthetic compounds that
exhibit a potential to elicit negative effects on endocrine
systems of humans and wildlife. The group of EDCs in-
cludes natural and synthetic estrogen hormones, phar-
maceuticals, pesticides, industrial chemicals, such as poly-
cyclic aromatic hydrocarbons (PAHs), polychlorinated
biphenyl (PCB), surfactants and plasticizers, and heavy
metals (1–4). Natural and synthetic estrogens generally
display much stronger estrogenic effects than phyto-
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and xenoestrogens. However, the concentrations of the
latter compounds in the aquatic environment are usual-
ly several orders of magnitude higher than those of estro-
gens (4,5).
EDCs can be hormonally active at low concentrations,
and recent studies have reported their presence in waste-
water, surface water, groundwater and even drinking
water worldwide at significantly higher concentrations,
therefore these findings are a cause for concern (6,7).
Human population is exposed to EDCs in food, water
and environment. Recent reviews and scientific consen-
sus statements find evidence of adverse reproductive out-
comes, i.e. infertility, cancers, malformations, and effects
on other endocrine systems from exposure to EDCs (5,
8,9). Therefore, efficient wastewater treatment technolo-
gies and control of effluent quality are very important
steps in prevention of the pollution of drinking water
with EDCs. Traditionally, quality control of effluents is
mainly based on analytical measurements of target com-
pounds such as EDCs. However, environmental samples
are almost always complex mixtures of known and un-
known chemicals, which makes complete identification
and quantification of all present compounds, as well as
by-products or metabolites, unfeasible and economically
unacceptable. Furthermore, adverse biological effects
caused by EDCs cannot be measured by chemical anal-
yses. For this reason, a biological assay, such as in vitro
yeast estrogen screen (YES) assay, is required for screen-
ing the estrogenic activity of environmental samples, i.e.
effluents, wastewater and landfill leachates (3,4,7,10,11).
An estrogenic activity identification and evaluation pro-
cedure by means of YES assay has been described in many
papers (5,12–14).
Since the amounts of some EDCs in the environment
are at trace levels, samples must undergo extraction and
concentration procedures to reach the levels of detection
(15). Several solid-phase extraction (SPE) procedures for
extraction and concentration of wastewater have been de-
scribed by authors such as Ballesteros et al. (16), Janex-
-Habibi et al. (17), Yang et al. (18), etc.
The aim of this study is to optimize the in vitro YES
assay as a tool for detecting estrogenic activity of aqueous
samples. For this purpose, some important parameters
were investigated, such as time of exposure, absorbance
maximum and concentration of chromogenic substrate
chlorophenol red b-D-galactopyranoside (CPRG) added to
the assay medium. Specificity of the assay was assessed
by several known estrogenic compounds. For the detec-
tion of estrogenic activity in water samples, an SPE pro-
cedure was optimized for the extraction and concentra-
tion of estrogenic-active compounds from aqueous samples.
Finally, the introduced YES bioassay was used to inves-
tigate the estrogenic activity of influents and effluents




Compounds 17-b-estradiol (E2), 17-a-ethinylestradiol
(EE2), bisphenol A (BPA), nonylphenol (NP), genisteine
(G), hydrocortisone (HC), dieldrin (D), atrazine (A), me-
thoxychlor (M), testosterone (T) and progesterone (P)
were purchased from Sigma-Aldrich (Munich, Germany).
Samples for testing specificity and sensitivity of YES
assay were prepared in 1 mL of 99 % ethanol (Fluka,
Sigma-Aldrich). Working mass concentrations of com-
pounds were 27.2 mg/L for E2; 29.6 mg/L for EE2; 0.2
mg/L for BPA and G; 93.7 mg/L for NP; 36.2 mg/L for
HC; 10 g/L for D, A and M; 28.8 mg/L for T and 31.4
mg/L for P.
For the solid-phase extraction (SPE) procedure, aque-
ous solutions of E2 (272, 27.2 and 2.72 mg/L), EE2 (296,
29.6 and 2.96 mg/L), BPA (0.2, 0.1 and 0.05 g/L) and G
(0.2 g/L) were prepared in ultrapure water. Stock concen-
tration of chlorophenol red b-D-galactopyranoside (CPRG)
substrate was 10 mg/mL.
YES assay procedure
A recombinant yeast strain Saccharomyces cerevisiae
BJ1991 used in this experiment was kindly provided by
Professor John P. Sumpter (Genetics Department of Gla-
xo Wellcome, Stevenage, UK). Yeast hosts an integrated
gene coding for human estrogen receptor (hER) in its
genome and expression plasmids carrying the reporter
gene lac-Z (encoding the enzyme b-galactosidase). Fol-
lowing the activation of lac-Z gene in the presence of
estrogenic-active compounds, b-galactosidase degrades
CPRG substrate (13).
Preparation of medium components
All the ingredients were purchased from Sigma-Al-
drich. Minimal medium and growth medium were pre-
pared following Routledge and Sumpter (13). The growth
medium was inoculated with 0.25 mL of the concentrat-
ed stock yeast and incubated at 28 °C for approx. 24 h on
an orbital shaker (150 rpm) until A620 nm=1.0 was reached.
The assay medium was prepared by adding 200 mL of
the chromogenic substrate CPRG (g=10 mg/mL) to 50
mL of fresh growth medium and seeded with 2 mL of
yeast from a 24-hour yeast culture. Serial dilutions of
compounds were prepared in ethanol and 10-mL aliquots
of these solutions were transferred to 96-well flat-bottom
microtiter plates under sterile conditions. After the etha-
nol dried, the yeast cells in the assay medium were add-
ed to each hole on the microtiter plate. Then, microtiter
plates were incubated at 34 °C for 48–52 h. The absor-
bance of each sample was measured on the microtiter plate
reader PowerWave XS (BioTek, Winooski, VT, USA). On
each microtiter plate positive, negative and blank con-
trols were used. Since 17-b-estradiol (E2) is the main nat-
ural human estrogen, it was used as a positive control.
On the other hand, testosterone (T) and progesterone (P)
are natural human hormones without the ability of bind-
ing to the human estrogen receptor; therefore, they were
used as a negative control. As a blank control (BC), yeasts
exposed to the growth medium with CPRG substrate
were used in order to detect whether yeasts themselves,
without exposure to estrogenic-active compounds, could
degrade CPRG.
YES assay optimization
The YES assay was optimized for incubation time
(by the absorbance measurements at different time inter-
vals), concentration of the CPRG substrate in the assay
medium (10, 20, 40, 60 and 80 mg/mL) and the maximal
absorption wavelength for degraded CPRG substrate
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(scan in a range from 500 to 600 nm), by using com-
pounds E2, EE2 and BPA.
Estrogenic activity
For calculating estrogenic activity (EA), the absor-
bance measurements (A) at 575 and 620 nm were carried
out, and EA was expressed as the activity of enzyme b-ga-
lactosidase. Equation adopted by Fent et al. (12) reads:
b-galactosidase activity (EA)=A575 nm(sample)–
–(A620 nm(sample)–A620 nm(blank))
/1/
where A575 nm(sample) represents the absorbance of the
sample measured at 575 nm, A620 nm(sample) represents the
absorbance of the sample measured at 620 nm, while
A620 nm(blank) represents the turbidity of yeast in the assay
medium.
Solid-phase extraction procedure (SPE procedure)
Optimization of the SPE procedure involved testing
of two different SPE cartridges SupelcleanTM ENVI 18-
-SPE (Supelco, Sigma-Aldrich, St. Louis, MO, USA) and
Oasis® HLB SPE (Waters Milford, MA, USA), and elut-
ing solvents methanol and ethyl acetate. Conditioning of
cartridges was performed with 4 mL of methanol or
ethyl acetate, followed by 4 mL of distilled water. After
loading the samples, the cartridges were washed with 5
% methanol or 5 % ethyl acetate. During these steps,
vacuum was maintained. Then the cartridges were dried
under a gentle stream of nitrogen (N2) and compounds
were eluted with 4 mL of methanol or ethyl acetate and
collected in test tubes. Eluted samples in test tubes were
exposed to the gentle stream of N2 to concentrate the
samples to the volume of 1 mL and stored at –20 °C be-
fore further use. Recovery of compounds E2, EE2, BPA
and G was calculated according to the following equa-
tion:
Recovery=(EASPE sample/EAsample)·100 /2/
Estrogenic activity (EAsample) and estrogenic activity
after SPE procedure (EASPE sample) of the samples were
calculated using Eq. 1. In order to test for significant dif-
ferences between recoveries obtained for both cartridges
and eluting solvents, Student’s t-test (p<0.05) was used.
Wastewater samples
Influent and effluent grab samples from two waste-
water treatment plants (WWTPs), WWTP1 and WWTP2,
were collected in 5-litre plastic bottles. Wastewater marked
as WW1 was collected from the wastewater treatment
plant where municipal and industrial wastewaters flow
in (WWTP1), whereas wastewater labelled WW2 was
collected from the municipal wastewater treatment plant
(WWTP2). Collected wastewater samples were processed
immediately upon arrival. Pretreatment of samples (250
mL) involved centrifugation at 5000 rpm for 10 min and
filtration through the 1.2- and 0.3-mm membrane filters
(16). This was followed by the SPE procedure, where
methanol and ethyl acetate were used as conditioning
and eluting solvents on the same SPE cartridge (ethyl
acetate followed methanol). Extracted and concentrated
samples were stored at –20 °C before they were used in
YES assay.
The estrogenic activity of wastewater samples was
expressed as the activity of b-galactosidase calculated by
using Eq. 1 and the relative estrogenic activity (REA/%)
was calculated using the following equation, adopted by
Cajthaml et al. (19):
REA=(EAsample–EAblank)/D·100 /3/
where EAsample is estrogenic activity of the sample calcu-
lated using Eq. 1, EAblank is the average of blank control es-
trogenic activity calculated using Eq. 1 and D is an inter-
val of estrogenicity with the initial point at the highest
EAE2 value and final point in EAblank.
Enzymatic deconjugation
For activation of conjugated estrogens, deconjugation
step has to be performed. According to Mouatassim-Sou-
ali et al. (20), the wastewater extract from SPE procedure
was evaporated to dryness under N2 gas. Then, the
samples were redissolved in 1 mL of 0.1 M acetic acid
buffer (pH=5) containing b-glucuronidase with minimum
2000 units of glucuronidase and 150 units of sulphatase
activity (HP-2 from Helix pomatia (Sigma-Aldrich)). After
24 h of incubation at 40 °C, the reaction of deconjuga-
tion was terminated by the addition of acidified water
(pH=3). The incubation mixture was then extracted on
preconditioned Oasis HLB® SPE cartridge as described
previously. Estrogenic activity and relative estrogenic ac-
tivity were calculated using Eqs. 1 and 3.
Results
YES assay procedure optimization
Absorbance of yeast culture suitable for use in the
assay was at A620 nm=1. This was reached between 18 and
24 h of incubation at 28 °C on an orbital shaker at 140
rpm. Furthermore, the YES assay optimization showed
that yeast should be exposed to the tested samples be-
tween 48 and 58 h in order to obtain sigmoidal curves
(Fig. 1). When the YES assay is prolonged to 72 h, the
response curve has different shape (Fig. 1). The CPRG
degradation product might acquire estrogenic activity and





























Fig. 1. Optimization of incubation time using standard E2: ()
48 h, () 51 h, () 55 h, () 58 h, () 72 h. Arithmetic means
and standard deviation (N=2) of activity of b-galactosidase are
presented
therefore false positive results could be obtained, which
was also confirmed by Vanderperren et al. (21).
Scan of visible light absorption in a wavelength range
from 500 to 600 nm showed the highest obtained absor-
bance at the wavelength of 575 nm (data not shown).
According to Routledge and Sumpter (13), 300 mL of CPRG
(60 mg/mL) should be added to the assay medium. How-
ever, our results indicated that smaller volume of CPRG
such as 200 mL (40 mg/mL) also gives satisfactory results
(Fig. 2).
Specificity and sensitivity of YES assay
Specificity and sensitivity of YES assay were studied
using compounds E2, EE2, BPA, NP, G, HC, M, D, A, T
and P (Fig. 3 and Table 1). The obtained results show
that E2, EE2, BPA, NP, G and M possess estrogenic ac-
tivity, whereas other tested compounds do not bind to
the estrogen receptor (Fig. 3). Sensitivity of the tested
compounds is presented according to Kuruto-Niwa et al.
(22) as concentrations at which the lowest, 50 % of the
highest and the highest estrogenic effect are observed
(Table 1).
SPE procedure optimization
In general, the obtained recoveries for both car-
tridges were in the same range for all tested compounds
(Table 2). The obtained recoveries using methanol and
ethyl acetate on the SupelcleanTM ENVI 18-SPE cartridge
were similar. However, we observed some white turbid-
ity of the ethyl acetate when we dropped it into holes of



























Fig. 2. Optimization of CPRG concentration (in mg/mL) in the
assay medium: () 80, () 60, () 40, () 20, () 10 and () BC
(blank control). Arithmetic means and standard deviation (N=2)
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Fig. 3. Specificity of YES assay for: () E2, () EE2, () BPA, () NP, () G, () HC, (+) M, (–) D, () A, () T, () P and () BC
(blank control). Arithmetic means and standard deviation (N=2) of the activity of b-galactosidase are presented




E2 0.015±0.002 0.044±0.004 0.34±0.03
EE2 0.015±0.002 0.042±0.004 0.37±0.04
bisphenol A 78±7 337±30 5000±100
nonylphenol 0.073±0.007 0.32±0.03 1.17±0.1
genisteine 313±30 1290±90 5000±150
methoxychlor 1953±200 11400±800 250000±2000
aconcentration at which the lowest estrogenic effect was observed
bconcentration at which 50 % of the highest estrogenic effect
was observed
cconcentration at which the highest estrogenic effect was observed
Table 2. Recovery of E2, EE2, bisphenol A and genisteine using
different SPE cartridges and eluting solvents
Compound
Recovery/%
SupelcleanTM ENVI 18 Oasis® HLB
Methanol Ethyl acetate Methanol
E2a 99.3±0.7 95.2±4.8 99.3±0.7
EE2b 100.8±1.0 83.3±16.7 91.0±9.0
bisphenol Ac 97.4±2.6 95.5±4.5 91.4±8.6
genisteinec 100.6±0.6 90.4±9.6 83.0±17
a–cconcentrations of 13.6 mg/L (E2), 14.8 mg/L (EE2) and 10 mg/L
(BPA and G), respectively
arithmetic means and standard deviation (N=10–20) are pre-
sented
the microtiter plate in the YES assay. It seems that ethyl
acetate reacts with the plastic of the microtiter plate. For
this reason, further experiments for the optimization of
SPE procedure were conducted only with methanol. In
the SPE procedure of wastewater samples, ethyl acetate
in the vials was dried out under gentle stream of nitrogen
and then replaced by methanol. Some additional concen-
trations of E2, EE2 and BPA were tested by using Oasis®
HLB cartridges (Fig. 4). Results showed that the reco-
very rates are about 100 % at the highest tested concen-
trations, but they decreased at lower concentrations of
E2, EE2 and BPA (Fig. 4).
Wastewater samples
Influent and effluent samples examined by YES assay
indicated estrogenic activity as described in Tables 3 and
4. When yeast growth was inhibited for 50 % or more
due to toxic compounds present in the tested samples,
the REA was not calculated due to possible false results.
Influent concentrates of WW1 eluted by methanol
(WW1-influent-MeOH) caused high inhibition (up to 90
%) of yeast growth and consequently REA was not de-
termined (n.d.). When influent concentrates were eluted
by ethyl acetate (WW1-influent-EtAc), up to 62 % of REA
was determined before deconjugation, but after it the REA
increased up to 93 %. Although effluent concentrates were
less toxic than influents, similar REA was determined.
However, REA stayed at the same level or even slightly
decreased in the effluent concentrates after deconjuga-
tion; this could be explained by deconjugation of estro-
gens during treatment processes in WWTP and/or loses
of EDCs due to repeating SPE procedures.
WW2 influent and effluent concentrates revealed
lower toxicity manifested in growth inhibition of yeast
and REA in comparison with WW1 influent and effluent
samples (Table 4). No estrogenic activity was detected
either in the influent concentrates (the concentrates with
growth inhibition lower than 50 %) or in the effluent
concentrates. However, after deconjugation step up to 46
and 48 % of REA was determined in influent and efflu-
ent concentrates, respectively.
Discussion
In the present work, YES assay and SPE procedure
were optimized for testing estrogenic activity of water
samples. Firstly, the specificity of YES assay was tested
for the selected chemicals. Specificity of YES assay is ex-
plained by the nature of the estrogen receptor, where
ligand-binding site is larger and more flexible than the
17-b-estradiol molecule requires (22,23). This makes the
estrogen receptor more vulnerable as a target for inter-
ference by many different compounds with analogy in
















Fig. 4. Recovery of SPE procedure for E2, EE2 and BPA: ()
13.6 mg/L of E2, 14.8 mg/L of EE2 and 10 mg/L of BPA, ()
1.36 mg/L of E2, 1.48 mg/L of EE2 and 5 mg/L of BPA and ()
0.136 mg/L of E2, 0.148 mg/L of EE2 and 2.5 mg/L of BPA. Arith-
metic means and standard deviation (N=16) of recovery calcu-
lated from the activity of b-galactosidase are presented


















12.5 n.d. 62.1 n.d. 57.1
6.3 n.d. 59.2 37.7 51.6
3.1 n.d. 47.8 32.8 34.7
















12.5 n.d. 93.4 n.d. 31.1
6.3 n.d. 60.6 32.4 14.8
3.1 n.d. 24.5 6.2 0
1.6 0 0 0 0
n.d.=not determined (growth inhibition was 50 % or more)


















12.5 n.d. 0 0 0
6.3 n.d. 0 0 0
3.1 0 0 0 0
















12.5 37.5 46.1 0 47.6
6.3 26.7 15.3 0 28.8
3.1 0 0 0 0
1.6 0 0 0 0
n.d.=not determined (growth inhibition was 50 % or more)
chemical structure, such as synthetic estrogen hormone
(EE2), industrial chemicals (BPA, NP), phytoestrogen (ge-
nisteine) or pesticide (methoxychlor). On the other hand,
homology does not play any role, since among the group
of steroid hormones 17-b-estradiol (E2), hydrocortisone
(HC), testosterone (T) and progesterone (P), by the com-
mon origin from cholesterol, only E2 caused estrogenic
activity (with the ability of binding with the estrogen re-
ceptor). All chemicals showed an activation of the estro-
gen receptor in a concentration-dependent manner. The
observed sensitivity of YES assay to natural and syn-
thetic estrogens is in the same range (15 ng/L), whereas
its sensitivity to nonylphenol (NP) is 5-times lower (73
ng/L), to bisphenol A (BPA) and genisteine (G) more
than 5000 times lower (78 mg/L for BPA and 312 mg/L
for G) and to methoxychlor (M) more than 100 000 times
lower (2 mg/L). The presented results are comparable to
the previously described results by Routlegde and Sum-
pter (13), Daston et al. (25), Giesy et al. (26) and Ternes et
al. (27).
In our case, the incubation time of YES assay was
between 48 and 58 h, the absorbance of the degraded
CPRG substrate was measured at the wavelength of 575
nm as it provides about 75 % higher response in compa-
rison with the measurements at 540 nm, and the volume
of CPRG substrate added to the assay medium was
equal to 200 mL (which corresponds to the concentration
of CPRG in the assay medium equal to 40 mg/mL).
While Routledge and Sumpter (13) showed estrogenic
activity as the absorbance of degraded CPRG substrate
measured at 540 nm, in our work estrogenic activity was
presented as the activity of b-galactosidase calculated by
Eq. 1.
Introducing and optimizing the SPE procedure, Oa-
sis® HLB sorbent cartridge and the use of methanol as
eluting solvent were found to be the most optimal. Re-
covery of SPE procedure was above 60 % in all cases
and is comparable to the previously reported data by Bal-
lesteros et al. (16) and Lopez de Alda and Barceló (28).
The highest recovery (above 90 %) was obtained at the
highest tested concentrations followed by the medium
concentration (recovery above 80 %). As expected, the
lowest recovery (above 60 %) was found at the lowest
tested concentrations of the examined compounds E2,
EE2 and BPA.
Concentrated samples of influent and effluent exa-
mined for estrogenic activity indicated up to 90 % of REA.
In general, EA of influents was higher than the EA de-
termined in effluents, which could be explained by the
removal of estrogens and xenoestrogens during treat-
ment processes in WWTPs (29–31). Furthermore, the EA
of the tested samples after deconjugation step increased
in most cases in comparison with the original samples,
which means that the present estrogens were in inactive
(conjugated) form and became active only after deconju-
gation. This was not the case for the effluent sample ob-
tained from the WWTP1 (WW1-effluent-EtAc) as lower
EA level was obtained when concentrates were eluted
with ethyl acetate. This could be explained by possible
elimination of estrogenic compounds from water samples
due to repeated SPE procedures before and after decon-
jugation step.
Conclusions
The obtained results showed that the optimized YES
assay was sensitive and specifically responded to the se-
lected estrogenic and nonestrogenic compounds in water
samples. The introduced YES assay was then applied to
assess the estrogenicity of concentrated influent and
effluent samples from two municipal WWTPs. Up to 90
% of relative estrogenic activity of influent and effluent
samples was detected, which was probably due to the
presence of natural and synthetic estrogen hormones and
xenoestrogens from households. Lower estrogenic activ-
ity was found in effluent and influent samples of the
WWTP2 (up to 48 %) in comparison with the samples
obtained from the WWTP1 (up to 93 %). However, both
WWTPs were partially successful in removing EDCs, since
estrogenic activity was still present in most concentrated
effluent samples.
We can conclude that the introduced YES assay is a
suitable screening tool for monitoring the potential estro-
genicity of effluents which are discharged into surface
waters. Only effective removal of EDCs from wastewater
using appropriate treatment processes could protect the
aquatic environment reliably from pollution with these
compounds and consequently prevent adverse effects on
wildlife and humans.
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